Infliximab in the treatment of Crohn’s disease

The recent introduction of infliximab, a chimeric monoclonal antibody against tumor necrosis factor-α, has greatly modified the treatment of Crohn’s disease (CD). Data from the literature show encouraging results after intravenous infusion both for closure of intestinal or perianal fistulas and for...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Poggioli, Gilberto, Laureti, Silvio, Campieri, Massimo, Pierangeli, Filippo, Gionchetti, Paolo, Ugolini, Federica, Gentilini, Lorenzo, Bazzi, Piero, Rizzello, Fernando, Coscia, Maurizio
Formato: Artigo
Lenguaje:Inglês
Publicado: Dove Medical Press 2007
Materias:
Reviews
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC1936311/
https://ncbi.nlm.nih.gov/pubmed/18360638
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares